Integrated Anchor Delivery System for Minimally Invasive Tissue Retraction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for Benign Prostatic Hyperplasia (BPH) and urinary incontinence often involve invasive procedures with high risks of adverse effects, lengthy recovery times, and suboptimal symptom relief, while minimally invasive methods may require hospital stays and urethral catheterization, leading to discomfort and delayed relief.
Innovation Solution
An integrated anchor delivery system that deploys anchor assemblies within the body to retract, lift, or compress tissues, allowing for minimally invasive procedures with reduced trauma and discomfort, featuring a device capable of delivering and assembling anchor components, cutting to desired length, and facilitating ultrasound visibility and therapeutic substance delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional surgical procedures are used to treat BPH and urinary incontinence, then effective symptom relief is achieved, but invasive procedures with high risks of adverse effects and lengthy recovery times occur
Solution Approach 1:
The treatment system divides the anchor assembly into multiple separable components (first anchor component, second anchor component, connector) that can be delivered and assembled separately within the body, enabling minimally invasive placement while maintaining effective tissue support and symptom relief
Solution Approach 2:
A delivery device serves as an intermediary tool to implant the anchor components through minimally invasive approaches, facilitating the assembly of anchor components within the body without requiring traditional open surgery, thereby reducing procedural risks while achieving effective treatment
2Loss of time
If minimally invasive procedures are used to reduce trauma and discomfort, then recovery time is shortened, but the procedures may require hospital stays and urethral catheterization
Solution Approach 1:
The anchor assembly is designed to be self-assembling within the body through the delivery device, where the connector automatically engages with the anchor components upon insertion, eliminating the need for complex post-procedure assembly steps, hospital stays, or urethral catheterization while maintaining minimal invasiveness and short recovery time
3Ease of operation
If anchor assemblies are deployed to retract and lift tissues, then effective tissue manipulation is achieved, but precise delivery and assembly control are required
Solution Approach 1:
The delivery device integrates multiple functions into a single unified system, combining the delivery of anchor components, the assembly of anchor parts through the connector, and the deployment of the complete anchor assembly in one procedure, thereby simplifying the operational sequence while achieving effective tissue manipulation
Solution Approach 2:
The anchor components and connector are pre-assembled or pre-positioned within the delivery device before insertion, so that upon deployment they automatically assemble in the correct configuration within the body, eliminating the need for complex real-time assembly control and simplifying the surgical procedure while maintaining precision
Data Source
Figure 1~2A
Figure 2B~2C
Figure 2D~2F
AI summary
Integrated systems and associated method for manipulating tissues and anatomical or other structures in medical applications for the purpose of treating diseases or disorders or other purposes. In one aspect, the system includes a delivery device configured to deploy and implant anchor devices for such purposes.